Canada Life’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
VPM
VCM
AIM
Canada Life's VCYT Position: Q1 2026 in Review
Canada Life reduced its Veracyte (VCYT) stake by 1.8% in Q1 2026, selling an estimated $48.3K and leaving 70,525 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1115.
Canada Life first reported a position in VCYT in Q2 2019 and has held it in 27 quarters since. The position peaked at $3.02M in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- Canada Life held 70,525 shares of Veracyte worth $2.27M as of Q1 2026.
- Canada Life sold 1,305 Veracyte shares in Q1 2026, an estimated $48.3K.
- Veracyte made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1115 holding.
- Canada Life first reported a position in Veracyte in Q2 2019 and has held it in 27 quarters since.
- Canada Life's Veracyte position peaked at $3.02M in Q4 2025.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.